Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits

Anesthesia and Analgesia

Volumn 109, Issue 4, 2009, Pages 1263-1272

  Ding, Qian ^a   Wang, Qiang ^a   Deng, Jiao ^a   Gu, Qiuhan ^a   Hu, Sheng ^a   Li, Yang ^a   Su, Binxiao ^a   Zeng, Yi ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; DIMETHYL SULFOXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYGEN; SEVOFLURANE; 1,3 BUTADIENE DERIVATIVE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; NITRILE; PROTEIN KINASE INHIBITOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOTONEURON; NEUROLOGIC EXAMINATION; NICK END LABELING; NONHUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; RABBIT; REPERFUSION; SCORING SYSTEM; SHAM PROCEDURE; SPINAL CORD ISCHEMIA; VERTEBRA; WESTERN BLOTTING; ABDOMINAL AORTA; ANIMAL; CELL SURVIVAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEMODYNAMICS; LIGATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; REPERFUSION INJURY; SPINAL CORD; TIME;

ANESTHETICS, INHALATION; ANIMALS; AORTA, ABDOMINAL; APOPTOSIS; BUTADIENES; CELL SURVIVAL; CONSTRICTION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEMODYNAMICS; MALE; METHYL ETHERS; MOTOR NEURONS; NEUROLOGIC EXAMINATION; NITRILES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RABBITS; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA; TIME FACTORS;

EID: 70349572472     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181b2214c     Document Type: Article

References (38)

1. MacArthur RG, Carter SA, Coselli JS, LeMaire SA. Organ protection during thoracoabdominal aortic surgery: rationale for a multimodality approach. Semin Cardiothorac Vasc Anesth 2005;9:143-149
2. Patel SS, Goa KL. Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia. Drugs 1996;51:658-700
3. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, Lu Z. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003;96:233-237 (Pubitemid 36042066)
4. Sakai H, Sheng H, Yates RB, Ishida K, Pearlstein RD, Warner DS. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007;106:92-99 (Pubitemid 46035408)
5. Kim H, Yi JW, Sung YH, Kim CJ, Kim CS, Kang JM. Delayed preconditioning effect of isoflurane on spinal cord ischemia in rats. Neurosci Lett 2008;440:211-216
6. Zhang B, Wei X, Cui X, Zhou H, Ding W, Li W. Desflurane affords greater protection than halothane in the function of mitochondria against forebrain ischemia reperfusion injury in rats. Anesth Analg 2008;106:1242-1249
7. Pape M, Englelhard K, Eberspächer E, Hollweck R, Kellermann K, Zintner S, Hutzler P, Werner C. The long-term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg 2006;103:173-179 (Pubitemid 44036054)
8. Wang J, Lei B, Popp S, Meng F, Cottrell JE, Kass IS. Sevoflurane immediate preconditioning alters hypoxic membrane potential changes in rat hippocampal slices and improves recovery of CA1 pyramidal cells after hypoxia and global cerebral ischemia. Neuroscience 2007;145:1097-1107 (Pubitemid 46441651)
9. 2+ and mitogen-activated protein kinase signaling. Anesthesiology 2005;103:532-539
10. 2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth Analg 2006;103:419-429
11. 2+ and mitogen-activated protein kinases. Anesthesiology 2005;102:606-615
12. Zou Z, Wang Y, Huang Y. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006;542:84-91 (Pubitemid 44066361)
13. Chen HT, Yang CX, Li H, Zhang CJ, Wen XJ, Zhou J, Fan YL, Huang T, Zeng YM. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts. Acta Pharmacol Sin 2008;29:931-941
14. Lee HT, Kim M, Song JH, Chen SW, Gubitosa G, Emala CW. Sevoflurane-mediated TGF-beta1 signaling in renal proximal tubule cells. Am J Physiol Renal Physiol 2008;294:F371-8 (Pubitemid 351199402)
15. Park HP, Jeon YT, Hwang JW, Kang H, Lim SW, Kim CS, Oh YS. Isoflurane preconditioning protects motor neurons from spinal cord ischemia: its dose-response effects and activation of mitochondrial adenosine triphosphate-dependent potassium channel. Neurosci Lett 2005;387:90-94 (Pubitemid 41134204)
16. Sang H, Cao L, Qiu P, Xiong L, Wang R, Yan G. Isoflurane produces delayed preconditioning against spinal cord ischemic injury via release of free radicals in rabbits. Anesthesiology 2006;105:953-960 (Pubitemid 44655506)
17. Scheller MS, Saidman LJ, Partridge BL. MAC of sevoflurane in human and the New Zealand white rabbit. Can J Anaesth 1988;35:153-156 (Pubitemid 18086002)
18. Wang Z, Chen X, Zhou L, Wu D, Che X, Yang G. Effects of extracellular signal-regulated kinase (ERK) on focal cerebral ischemia. Chin Med J (Engl) 2003;116:1497-1503 (Pubitemid 37461663)
19. Cho DG, Mulloy MR, Chang PA, Johnson MD, Aharon AS, Robison TA, Buckles TL, Byrne DW, Drinkwater DC Jr. Blockade of the extracellular signal-regulated kinase pathway by U0126 attenuates neuronal damage following circulatory arrest. J Thorac Cardiovasc Surg 2004;127:1033-1040
20. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab 2006;26:666-674
21. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology 2002;96:907-912 (Pubitemid 34266684)
22. Jacobs TP, Kempski O, Mckinley D, Dutka AJ, Hallenbeck JM, Feuerstein G. Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia. Stroke 1992;23:367-373
23. Xu Z, Wang BR, Wang X, Kuang F, Duan XL, Jiao XY, Ju G. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sci 2006;79:1895-1905 (Pubitemid 44485117)
24. Wang Q, Xiong L, Chen S, Liu Y, Zhu X. Rapid tolerance to focal cerebral ischemia in rats is induced by preconditioning with electroacupuncture: window of protection and the role of adenosine. Neurosci Lett 2005;381:158-162 (Pubitemid 40693161)
25. Pagliaro P, Gattullo D, Rastaldo R, Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci 2001;69:1-15 (Pubitemid 32536730)
26. Canas PT, Velly LJ, Labrande CN, Guillet BA, Sautou-Miranda V, Masmejean FM, Nieoullon AL, Gouin FM, Bruder NJ, Pisano PS. Sevoflurane protects rat mixed cerebrocortical neuronalglial cell cultures against transient oxygen-glucose deprivation: involvement of glutamate uptake and reactive oxygen species. Anesthesiology 2006;105:990-998 (Pubitemid 44655511)
27. Kehl F, Payne RS, Roewer N, Schurr A. Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res 2004;1021:76-81 (Pubitemid 39158659)
28. Zvara DA, Bryant AJ, Deal DD, DeMarco MP, Campos KM, Mansfield CM, Tytell M. Anesthetic preconditioning with sevoflurane does not protect the spinal cord after an ischemicreperfusion injury in the rat. Anesth Analg 2006;102:1341-1347
29. Zhang X, Xiong L, Hu W, Zheng Y, Zhu Z, Liu Y, Chen S, Wang X. Preconditioning with prolonged oxygen exposure induces ischemic tolerance in the brain via oxygen free radical formation. Can J Anaesth 2004;51:258-263 (Pubitemid 39010956)
30. Moore WM Jr, Hollier LH. The influence of severity of spinal cord ischemia in the etiology of delayed-onset paraplegia. Ann Surg 1991;213:427-431
31. Jacobs TP, Shohami E, Baze W, Burgard E, Gunderson C, Hallenbeck JM, Feuerstein G. Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. Stroke 1987;18:741-750 (Pubitemid 17093865)
32. Kim JM, Lee JC, Chang N, Chun HS, Kim WK. S-Allyl-L-cysteine attenuates cerebral ischemic injury by scavenging peroxynitrite and inhibiting the activity of extracellular signal-regulated kinase. Free Radic Res 2006;40:827-835 (Pubitemid 44480493)
33. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA 2001;98:11569-11574 (Pubitemid 32928769)
34. Kobayashi H, Minatoguchi S, Yasuda S, Bao N, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Tabata Y, Fujiwara H. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair. Cardiovasc Res 2008;79:611-620
35. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999;274:26563-26571 (Pubitemid 129520095)
36. Mody N, Leitch J Armstrong C, Dixon J, Choen P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett 2001;502:21-24 (Pubitemid 32722053)
37. 2+ influx via NMDA receptors and contributes to ischemic tolerance in the hippocampal CA1 region of rats. Life Sci 2006;79:1839-1846
38. Wang RM, Zhang QG, Li J, Yang LC, Yang F, Brann DW. The ERK5-MEF2C transcription factor pathway contributes to anti-apoptotic effect of cerebral ischemia preconditioning in the hippocampal CA1 region of rats. Brain Res 2009;1255:32-41